Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131I‐mIBG therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|1|5-11

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 5-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Upfront treatment of high‐risk neuroblastoma with a combination of 131I‐MIBG and Topotecan

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1886-1891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Upfront treatment of high‐risk neuroblastoma with a combination of 131I‐MIBG and Topotecan

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1886-1891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity

By  

Obesity Science & Practice, Vol. 2, Iss. 1, 2016-03 ,pp. : 13-23

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of electromagnetic therapy for urinary incontinence: A systematic review

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 34, Iss. 8, 2015-11 ,pp. : 713-722

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant human thyrotropin before 131I therapy in patients with nodular goitre: a meta‐analysis of randomized controlled trials

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 5, 2015-11 ,pp. : 702-710

John Wiley & Sons Inc

Access to resources Recommend Favorite